16-1211178-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM2PP3_ModerateBS2
The NM_021098.3(CACNA1H):c.4234C>T(p.Arg1412Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,460,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.4234C>T | p.Arg1412Trp | missense_variant | Exon 22 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000565831.6 | c.4234C>T | p.Arg1412Trp | missense_variant | Exon 21 of 33 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000638323.1 | c.4195C>T | p.Arg1399Trp | missense_variant | Exon 22 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000569107.5 | c.457C>T | p.Arg153Trp | missense_variant | Exon 5 of 17 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000564231.5 | c.457C>T | p.Arg153Trp | missense_variant | Exon 5 of 18 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000562079.5 | c.457C>T | p.Arg153Trp | missense_variant | Exon 5 of 17 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000637236.2 | n.*204C>T | non_coding_transcript_exon_variant | Exon 6 of 6 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.4234C>T | non_coding_transcript_exon_variant | Exon 22 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*2147C>T | non_coding_transcript_exon_variant | Exon 22 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000637236.2 | n.*204C>T | 3_prime_UTR_variant | Exon 6 of 6 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000640028.1 | n.*2147C>T | 3_prime_UTR_variant | Exon 22 of 35 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes Cov.: 35
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 247848Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134910
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460434Hom.: 0 Cov.: 50 AF XY: 0.00000413 AC XY: 3AN XY: 726508
GnomAD4 genome Cov.: 35
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
This sequence change replaces arginine with tryptophan at codon 1412 of the CACNA1H protein (p.Arg1412Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CACNA1H-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at